Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Göttlinger H[au]:

Search results

Items: 1 to 50 of 95

1.

Potent Enhancement of HIV-1 Replication by Nef in the Absence of SERINC3 and SERINC5.

Wu Y, Olety B, Weiss ER, Popova E, Yamanaka H, Göttlinger H.

MBio. 2019 Jun 11;10(3). pii: e01071-19. doi: 10.1128/mBio.01071-19.

2.

HIV-1 gag recruits PACSIN2 to promote virus spreading.

Popov S, Popova E, Inoue M, Wu Y, Göttlinger H.

Proc Natl Acad Sci U S A. 2018 Jul 3;115(27):7093-7098. doi: 10.1073/pnas.1801849115. Epub 2018 Jun 11.

3.

A Long Cytoplasmic Loop Governs the Sensitivity of the Anti-viral Host Protein SERINC5 to HIV-1 Nef.

Dai W, Usami Y, Wu Y, Göttlinger H.

Cell Rep. 2018 Jan 23;22(4):869-875. doi: 10.1016/j.celrep.2017.12.082. Epub 2018 Jan 28.

4.

Asymmetric ring structure of Vps4 required for ESCRT-III disassembly.

Caillat C, Macheboeuf P, Wu Y, McCarthy AA, Boeri-Erba E, Effantin G, Göttlinger HG, Weissenhorn W, Renesto P.

Nat Commun. 2015 Dec 3;6:8781. doi: 10.1038/ncomms9781.

5.

SERINC3 and SERINC5 restrict HIV-1 infectivity and are counteracted by Nef.

Usami Y, Wu Y, Göttlinger HG.

Nature. 2015 Oct 8;526(7572):218-23. doi: 10.1038/nature15400. Epub 2015 Sep 30.

6.

The Nef-like effect of murine leukemia virus glycosylated gag on HIV-1 infectivity is mediated by its cytoplasmic domain and depends on the AP-2 adaptor complex.

Usami Y, Popov S, Göttlinger HG.

J Virol. 2014 Mar;88(6):3443-54. doi: 10.1128/JVI.01933-13. Epub 2014 Jan 8. Erratum in: J Virol. 2014 May;88(10):5900.

7.

HIV-1 Nef responsiveness is determined by Env variable regions involved in trimer association and correlates with neutralization sensitivity.

Usami Y, Göttlinger H.

Cell Rep. 2013 Nov 14;5(3):802-12. doi: 10.1016/j.celrep.2013.09.028. Epub 2013 Oct 24.

8.

UPF1 is crucial for the infectivity of human immunodeficiency virus type 1 progeny virions.

Serquiña AK, Das SR, Popova E, Ojelabi OA, Roy CK, Göttlinger HG.

J Virol. 2013 Aug;87(16):8853-61. doi: 10.1128/JVI.00925-13. Epub 2013 Jun 19.

9.

Structural basis of tetherin function.

Weissenhorn W, Miguet N, Aschman N, Renesto P, Usami Y, Gottlinger HG.

Curr HIV Res. 2012 Jun;10(4):298-306. Review.

PMID:
22524178
10.

CC2D1A is a regulator of ESCRT-III CHMP4B.

Martinelli N, Hartlieb B, Usami Y, Sabin C, Dordor A, Miguet N, Avilov SV, Ribeiro EA Jr, Göttlinger H, Weissenhorn W.

J Mol Biol. 2012 May 25;419(1-2):75-88. doi: 10.1016/j.jmb.2012.02.044. Epub 2012 Mar 8.

11.

Regulation of CHMP4/ESCRT-III function in human immunodeficiency virus type 1 budding by CC2D1A.

Usami Y, Popov S, Weiss ER, Vriesema-Magnuson C, Calistri A, Göttlinger HG.

J Virol. 2012 Apr;86(7):3746-56. doi: 10.1128/JVI.06539-11. Epub 2012 Jan 18.

12.

Nef decreases HIV-1 sensitivity to neutralizing antibodies that target the membrane-proximal external region of TMgp41.

Lai RP, Yan J, Heeney J, McClure MO, Göttlinger H, Luban J, Pizzato M.

PLoS Pathog. 2011 Dec;7(12):e1002442. doi: 10.1371/journal.ppat.1002442. Epub 2011 Dec 15.

13.

Essential and supporting host cell factors for HIV-1 budding.

Dordor A, Poudevigne E, Göttlinger H, Weissenhorn W.

Future Microbiol. 2011 Oct;6(10):1159-70. doi: 10.2217/fmb.11.100. Review.

PMID:
22004035
14.

Structural basis for ESCRT-III CHMP3 recruitment of AMSH.

Solomons J, Sabin C, Poudevigne E, Usami Y, Hulsik DL, Macheboeuf P, Hartlieb B, Göttlinger H, Weissenhorn W.

Structure. 2011 Aug 10;19(8):1149-59. doi: 10.1016/j.str.2011.05.011.

15.

The role of cellular factors in promoting HIV budding.

Weiss ER, Göttlinger H.

J Mol Biol. 2011 Jul 22;410(4):525-33. doi: 10.1016/j.jmb.2011.04.055. Review.

16.

Essential ingredients for HIV-1 budding.

Weissenhorn W, Göttlinger H.

Cell Host Microbe. 2011 Mar 17;9(3):172-174. doi: 10.1016/j.chom.2011.03.005.

17.

Human immunodeficiency virus type 1 and related primate lentiviruses engage clathrin through Gag-Pol or Gag.

Popov S, Strack B, Sanchez-Merino V, Popova E, Rosin H, Göttlinger HG.

J Virol. 2011 Apr;85(8):3792-801. doi: 10.1128/JVI.02329-10. Epub 2011 Feb 2.

18.

Rescue of HIV-1 release by targeting widely divergent NEDD4-type ubiquitin ligases and isolated catalytic HECT domains to Gag.

Weiss ER, Popova E, Yamanaka H, Kim HC, Huibregtse JM, Göttlinger H.

PLoS Pathog. 2010 Sep 16;6(9):e1001107. doi: 10.1371/journal.ppat.1001107.

19.

Influenza exits the cell without an ESCRT.

Göttlinger HG.

Cell. 2010 Sep 17;142(6):839-41. doi: 10.1016/j.cell.2010.08.036.

20.

Human immunodeficiency virus type 1 nucleocapsid p1 confers ESCRT pathway dependence.

Popova E, Popov S, Göttlinger HG.

J Virol. 2010 Jul;84(13):6590-7. doi: 10.1128/JVI.00035-10. Epub 2010 Apr 28.

21.

Structural basis of HIV-1 tethering to membranes by the BST-2/tetherin ectodomain.

Hinz A, Miguet N, Natrajan G, Usami Y, Yamanaka H, Renesto P, Hartlieb B, McCarthy AA, Simorre JP, Göttlinger H, Weissenhorn W.

Cell Host Microbe. 2010 Apr 22;7(4):314-23. doi: 10.1016/j.chom.2010.03.005.

22.

A crescent-shaped ALIX dimer targets ESCRT-III CHMP4 filaments.

Pires R, Hartlieb B, Signor L, Schoehn G, Lata S, Roessle M, Moriscot C, Popov S, Hinz A, Jamin M, Boyer V, Sadoul R, Forest E, Svergun DI, Göttlinger HG, Weissenhorn W.

Structure. 2009 Jun 10;17(6):843-56. doi: 10.1016/j.str.2009.04.007.

23.

Divergent Bro1 domains share the capacity to bind human immunodeficiency virus type 1 nucleocapsid and to enhance virus-like particle production.

Popov S, Popova E, Inoue M, Göttlinger HG.

J Virol. 2009 Jul;83(14):7185-93. doi: 10.1128/JVI.00198-09. Epub 2009 Apr 29.

24.

Structure and function of ESCRT-III.

Lata S, Schoehn G, Solomons J, Pires R, Göttlinger HG, Weissenhorn W.

Biochem Soc Trans. 2009 Feb;37(Pt 1):156-60. doi: 10.1042/BST0370156. Review.

PMID:
19143622
25.

Role of the feline immunodeficiency virus L-domain in the presence or absence of Gag processing: involvement of ubiquitin and Nedd4-2s ligase in viral egress.

Calistri A, Del Vecchio C, Salata C, Celestino M, Celegato M, Göttlinger H, Palù G, Parolin C.

J Cell Physiol. 2009 Jan;218(1):175-82. doi: 10.1002/jcp.21587.

26.

Nef can enhance the infectivity of receptor-pseudotyped human immunodeficiency virus type 1 particles.

Pizzato M, Popova E, Göttlinger HG.

J Virol. 2008 Nov;82(21):10811-9. doi: 10.1128/JVI.01150-08. Epub 2008 Aug 20.

27.

Helical structures of ESCRT-III are disassembled by VPS4.

Lata S, Schoehn G, Jain A, Pires R, Piehler J, Gottlinger HG, Weissenhorn W.

Science. 2008 Sep 5;321(5894):1354-7. doi: 10.1126/science.1161070. Epub 2008 Aug 7.

28.

Structural basis for autoinhibition of ESCRT-III CHMP3.

Lata S, Roessle M, Solomons J, Jamin M, Gottlinger HG, Svergun DI, Weissenhorn W.

J Mol Biol. 2008 May 9;378(4):818-27. doi: 10.1016/j.jmb.2008.03.030. Epub 2008 Mar 20.

29.

Efficient and specific rescue of human immunodeficiency virus type 1 budding defects by a Nedd4-like ubiquitin ligase.

Usami Y, Popov S, Popova E, Göttlinger HG.

J Virol. 2008 May;82(10):4898-907. doi: 10.1128/JVI.02675-07. Epub 2008 Mar 5.

30.

HIV/AIDS: virus kept on a leash.

Göttlinger HG.

Nature. 2008 Jan 24;451(7177):406-8. doi: 10.1038/nature06364. No abstract available.

PMID:
18200012
31.

Human immunodeficiency virus type 1 Gag engages the Bro1 domain of ALIX/AIP1 through the nucleocapsid.

Popov S, Popova E, Inoue M, Göttlinger HG.

J Virol. 2008 Feb;82(3):1389-98. Epub 2007 Nov 21.

32.

ESCRT-I part II: forming the real ESCRT-I complex.

Weissenhorn W, Göttlinger H.

Cell Host Microbe. 2007 Jul 12;2(1):1-2.

33.

Intracellular trafficking and maturation of herpes simplex virus type 1 gB and virus egress require functional biogenesis of multivesicular bodies.

Calistri A, Sette P, Salata C, Cancellotti E, Forghieri C, Comin A, Göttlinger H, Campadelli-Fiume G, Palù G, Parolin C.

J Virol. 2007 Oct;81(20):11468-78. Epub 2007 Aug 8.

34.
35.

Dynamin 2 is required for the enhancement of HIV-1 infectivity by Nef.

Pizzato M, Helander A, Popova E, Calistri A, Zamborlini A, Palù G, Göttlinger HG.

Proc Natl Acad Sci U S A. 2007 Apr 17;104(16):6812-7. Epub 2007 Apr 5.

36.

How HIV-1 hijacks ALIX.

Göttlinger HG.

Nat Struct Mol Biol. 2007 Apr;14(4):254-6. No abstract available.

PMID:
17410087
37.

Targeting of AMSH to endosomes is required for epidermal growth factor receptor degradation.

Ma YM, Boucrot E, Villén J, Affar el B, Gygi SP, Göttlinger HG, Kirchhausen T.

J Biol Chem. 2007 Mar 30;282(13):9805-12. Epub 2007 Jan 29.

38.

Release of autoinhibition converts ESCRT-III components into potent inhibitors of HIV-1 budding.

Zamborlini A, Usami Y, Radoshitzky SR, Popova E, Palu G, Göttlinger H.

Proc Natl Acad Sci U S A. 2006 Dec 12;103(50):19140-5. Epub 2006 Dec 4.

39.

Structural basis for budding by the ESCRT-III factor CHMP3.

Muzioł T, Pineda-Molina E, Ravelli RB, Zamborlini A, Usami Y, Göttlinger H, Weissenhorn W.

Dev Cell. 2006 Jun;10(6):821-30.

40.

Characterization of prototype foamy virus gag late assembly domain motifs and their role in particle egress and infectivity.

Stange A, Mannigel I, Peters K, Heinkelein M, Stanke N, Cartellieri M, Göttlinger H, Rethwilm A, Zentgraf H, Lindemann D.

J Virol. 2005 May;79(9):5466-76.

41.

APOBEC3G incorporation into human immunodeficiency virus type 1 particles.

Zennou V, Perez-Caballero D, Göttlinger H, Bieniasz PD.

J Virol. 2004 Nov;78(21):12058-61.

42.

AIP1/ALIX is a binding partner for HIV-1 p6 and EIAV p9 functioning in virus budding.

Strack B, Calistri A, Craig S, Popova E, Göttlinger HG.

Cell. 2003 Sep 19;114(6):689-99.

43.

The interaction between HIV-1 Gag and human lysyl-tRNA synthetase during viral assembly.

Javanbakht H, Halwani R, Cen S, Saadatmand J, Musier-Forsyth K, Gottlinger H, Kleiman L.

J Biol Chem. 2003 Jul 25;278(30):27644-51. Epub 2003 May 19.

44.
45.

Cellular inhibitors with Fv1-like activity restrict human and simian immunodeficiency virus tropism.

Cowan S, Hatziioannou T, Cunningham T, Muesing MA, Gottlinger HG, Bieniasz PD.

Proc Natl Acad Sci U S A. 2002 Sep 3;99(18):11914-9. Epub 2002 Aug 1.

46.

Nef enhances human immunodeficiency virus type 1 infectivity in the absence of matrix.

Dorfman T, Popova E, Pizzato M, Göttlinger HG.

J Virol. 2002 Jul;76(13):6857-62.

47.
48.

The HIV-1 assembly machine.

Göttlinger HG.

AIDS. 2001;15 Suppl 5:S13-20. Review. No abstract available.

PMID:
11816161
49.

Nef-mediated resistance of human immunodeficiency virus type 1 to antiviral cytotoxic T lymphocytes.

Yang OO, Nguyen PT, Kalams SA, Dorfman T, Göttlinger HG, Stewart S, Chen IS, Threlkeld S, Walker BD.

J Virol. 2002 Feb;76(4):1626-31.

50.

A role for ubiquitin ligase recruitment in retrovirus release.

Strack B, Calistri A, Accola MA, Palu G, Gottlinger HG.

Proc Natl Acad Sci U S A. 2000 Nov 21;97(24):13063-8.

Supplemental Content

Loading ...
Support Center